{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:43:03Z","timestamp":1786326183136,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"University of Benin, Benin-City, Nigeria"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.biopha.2018.06.152","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T21:37:57Z","timestamp":1531345077000},"page":"566-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of amlodipine and valsartan on glibenclamide-treated streptozotocin-induced diabetic rats"],"prefix":"10.1016","volume":"106","author":[{"given":"I. Olapeju","family":"Bolanle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Kelly Inanemo","family":"Omogbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5213-3177","authenticated-orcid":false,"given":"E. Enitome","family":"Bafor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.06.152_bib0005","series-title":"Robins and Cotran Pathologic Basis of Disease.","article-title":"The endocrine system","author":"Maitra","year":"2010"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.06.152_bib0010","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus diabetes","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2018.06.152_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0378-8741(03)00148-X","article-title":"Hypoglycaemic effect of water extracts of aegle marmelos fruits in streptozotocin induced-diabetic rats","volume":"87","author":"Kamalakkanan","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2018.06.152_bib0020","first-page":"1050","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projection for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2018.06.152_bib0025","series-title":"Diabetes Mellitus. Fact Sheet","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.biopha.2018.06.152_bib0030","series-title":"Diabetes Mellitus. Fact Sheet","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.biopha.2018.06.152_bib0035","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimate of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2018.06.152_bib0040","series-title":"Prevention of Diabetes mellitus. Technical Series No 844","author":"World Health Organization","year":"1994"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2018.06.152_bib0045","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1007\/s00592-005-0177-z","volume":"42","author":"Mancia","year":"2005","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.biopha.2018.06.152_bib0050","unstructured":"H. Wen, S. Lin, N. Zhonghua, (1999). Renal protective effect of valsartan in diabetic rats: US National Library of Medicine National Institute of Health, 38 (3),157\u2013160."},{"key":"10.1016\/j.biopha.2018.06.152_bib0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33549\/physiolres.930111","article-title":"The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas","volume":"50","author":"Szkudelski","year":"2001","journal-title":"Physiol Res."},{"issue":"5","key":"10.1016\/j.biopha.2018.06.152_bib0060","first-page":"747","article-title":"Effects of metformin on potassium-adapted and non-adapted diabetic rats","volume":"11","author":"Owolabi","year":"2012","journal-title":"Trop. J. Pharm. Res."},{"issue":"10","key":"10.1016\/j.biopha.2018.06.152_bib0065","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/13880200902973803","article-title":"Hypoglycemic activity of aqueous seed extract of Hunteria Umbellate in normal and streptozotocin-induced diabetic rats","volume":"47","author":"Igbe","year":"2009","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2018.06.152_bib0070","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.06.152_bib0075","first-page":"647","article-title":"Haematological alterations in diabetic rats- role of adipocytokines and effects of citrus flavonoids","volume":"12","author":"Ayman","year":"2013","journal-title":"EXCLI J."},{"key":"10.1016\/j.biopha.2018.06.152_bib0080","first-page":"119","article-title":"Antidiabetic activities of aqueous leaves extract of Leonotis leonurus in streptozotocin induced diabetic rats","volume":"5","author":"Oyedemi","year":"2011","journal-title":"J. Med. Plant. Res."},{"key":"10.1016\/j.biopha.2018.06.152_bib0085","first-page":"156","article-title":"Improvement of insulin sensitivity by perindopril in spontaneously hypertensive and streptozotocindiabetic rats","volume":"34","author":"Arun","year":"2002","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.biopha.2018.06.152_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0009-8981(02)00300-5","article-title":"Measurement of erythrocyte lipids, lipid peroxidation, antioxidants and osmotic fragility in cervical cancer patients","volume":"326","author":"Kolanjiappan","year":"2002","journal-title":"Clin. Chim Acta"},{"key":"10.1016\/j.biopha.2018.06.152_bib0095","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0021-9150(97)00314-6","article-title":"Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance","volume":"137","author":"Laakso","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2018.06.152_bib0100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.ejcn.1602481","article-title":"A proposed method for assessing plasma hypertonicity in vivo","volume":"61","author":"Stookey","year":"2007","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2018.06.152_bib0105","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0140-6736(07)60821-6","article-title":"Acute and chronic complications of type 2 diabetes mellitus in children and adolescents","volume":"369","author":"Pinhas-Hamiel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2018.06.152_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0897190003261312","article-title":"An overview of diabetic nephropathy","volume":"17","author":"Nesbitt","year":"2004","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.biopha.2018.06.152_bib0115","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1073\/pnas.90.5.1814","article-title":"Expression of transforming growth factor \u03b2 is elevated in human and experimental diabetic nephropathy","volume":"90","author":"Yamamoto","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.biopha.2018.06.152_bib0120","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1182\/blood.V90.10.4126","article-title":"Biochemical and molecular characterization of hereditary myeloperoxidase deficiency","volume":"15","author":"Romano","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.06.152_bib0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/sj.ejcn.1601367","article-title":"Depression of the glycaemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes","volume":"56","author":"Jenkins","year":"1996","journal-title":"Eur. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.biopha.2018.06.152_bib0130","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/diab.45.12.1661","volume":"45","author":"Saltiel","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2018.06.152_bib0135","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s001250050718","article-title":"High density lipoprotein apolipoprotein Al kinetics in NIDDM: a stable isotope study","volume":"40","author":"Frenais","year":"1997","journal-title":"Diabetologia"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218326982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218326982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:50:55Z","timestamp":1762311055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218326982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":27,"alternative-id":["S0753332218326982"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.152","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of amlodipine and valsartan on glibenclamide-treated streptozotocin-induced diabetic rats","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}